National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR) Announces the Availability of the NTP-CERHR Monograph on Bisphenol A, 51483-51484 [E8-20297]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 171 / Wednesday, September 3, 2008 / Notices
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 1114. Please
use the C Street entrance closest to 3rd
Street and bring photo ID for entry to a
Federal building.
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
confidentiality/.
SUPPLEMENTARY INFORMATION: The
Workgroup Members will continue
discussing and evaluating the
confidentiality, privacy, and security
protections and requirements for
participants in electronic health
information exchange environments.
The meeting will be available via Web
cast. For additional information, go to:
https://www.hhs.gov/healthit/ahic/
cps_instruct.html.
ADDRESSES:
Dated: August 5, 2008.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. E8–20332 Filed 9–2–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Consumer Empowerment
Workgroup Meeting
sroberts on PROD1PC70 with NOTICES
Announcement of meeting.
SUMMARY: This notice announces the
29th meeting of the American Health
Information Community Consumer
Empowerment Workgroup in
accordance with the Federal Advisory
Committee Act (Pub. L. 92–463, 5
U.S.C., App.).
DATES: September 16, 2008, from 1 p.m.
to 4 p.m. [Eastern].
ADDRESSES: Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 1114. Please
use the C Street entrance closest to 3rd
Street and bring photo ID for entry to a
Federal building.
FOR FURTHER INFORMATION CONTACT:
https://www.hhs.gov/healthit/ahic/
consumer/.
SUPPLEMENTARY INFORMATION: The
Workgroup will continue its discussion
on how to encourage the widespread
adoption of a personal health record
that is easy-to-use, portable,
longitudinal, affordable, and consumercentered.
VerDate Aug<31>2005
22:59 Sep 02, 2008
Jkt 214001
Dated: August 5, 2008.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. E8–20333 Filed 9–2–08; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Population Health and
Clinical Care Connections Workgroup
Meeting
ACTION:
BILLING CODE 4150–45–P
ACTION:
The meeting will be available via Web
cast. For additional information, go to:
https://www.hhs.gov/healthit/ahic/
consumer/ce_instruct.html.
Announcement of meeting.
SUMMARY: This notice announces the
30th meeting of the American Health
Information Community Population
Health and Clinical Care Connections
Workgroup in accordance with the
Federal Advisory Committee Act (Pub.
L. 92–463, 5 U.S.C., App.)
September 17, 2008, from 2 p.m.
to 5 p.m. [Eastern Time].
DATES:
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 1114. Please
use the C Street entrance closest to 3rd
Street and bring photo ID for entry to a
Federal building.
ADDRESSES:
https://
www.hhs.gov/healthit/ahic/population/.
FOR FURTHER INFORMATION:
The
Workgroup will continue its discussion
on how to facilitate the flow of reliable
health information among population
health and clinical care systems
necessary to protect and improve the
public’s health. The meeting will be
available via Web cast. For additional
information, go to: https://www.hhs.gov/
healthit/ahic/population/
pop_instruct.html.
SUPPLEMENTARY INFORMATION:
Dated: August 5, 2008.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. E8–20334 Filed 9–2–08; 8:45 am]
BILLING CODE 4150–45–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
51483
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP)
Center for the Evaluation of Risks to
Human Reproduction (CERHR)
Announces the Availability of the NTP–
CERHR Monograph on Bisphenol A
National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH).
ACTION: Availability of the NTP–CERHR
Monograph on Bisphenol A.
AGENCY:
SUMMARY: In December 2005, the CERHR
announced its intention to conduct an
evaluation of the potential for bisphenol
A to cause adverse effects on
reproduction and development in
humans (Federal Register: December 21,
2005: Vol. 70, No. 244, page 75827). The
final results of this evaluation are now
available in the NTP–CERHR
Monograph on Bisphenol A that
includes the (1) NTP Brief on Bisphenol
A and (2) CERHR Expert Panel Report
on the Reproductive and Developmental
Toxicity of Bisphenol A. The NTP Brief
provides the public, as well as
government health, regulatory, and
research agencies, with the NTP’s
conclusions regarding the potential for
bisphenol A to adversely affect human
reproductive health or children’s
development. The NTP Brief is based on
information about bisphenol A provided
in the expert panel report, public
comments, comments from peer
reviewers of the draft NTP Brief, and
additional scientific information
available since the expert panel
meeting.
DATES: The NTP–CERHR Monograph on
Bisphenol A will be available on
September 3, 2008.
ADDRESSES: The NTP–CERHR
Monograph on the Potential Human
Reproductive and Developmental
Effects of Bisphenol A is now available
electronically on the CERHR Web site
(https://cerhr.niehs.nih.gov see ‘‘Now
Available’’) or on CD or in printed text
from the CERHR by contacting Dr.
Michael D. Shelby, CERHR Director,
NIEHS, P.O. Box 12233, MC EC–32,
Research Triangle Park, NC 27709
(mail), 919–316–4511 (fax), or
shelby@niehs.nih.gov (e-mail). Courier
address: CERHR, 79 T.W. Alexander
Drive, Building 4401, Room 103,
Research Triangle Park, NC 27709.
Additional information related to the
evaluation of bisphenol A, including the
peer review report for the NTP Brief and
all public comments received during the
course of the evaluation, are available
on the CERHR Web site (see Bisphenol
E:\FR\FM\03SEN1.SGM
03SEN1
51484
Federal Register / Vol. 73, No. 171 / Wednesday, September 3, 2008 / Notices
A under ‘‘CERHR Reports &
Monographs’’ or directly at https://
cerhr.niehs.nih.gov/chemicals/
bisphenol/bisphenol-eval.html.)
SUPPLEMENTARY INFORMATION:
sroberts on PROD1PC70 with NOTICES
Background Information on Bisphenol
A
Bisphenol A (CAS RN: 80–05–7) is a
high production volume chemical used
primarily in the production of
polycarbonate plastics and epoxy resins.
Polycarbonate plastics are used in some
food and drink containers; the resins are
used as lacquers to coat metal products
such as food cans, bottle tops, and water
supply pipes. To a lesser extent
bisphenol A is used in the production
of polyester resins, polysulfone resins,
polyacrylate resins, and flame
retardants. In addition, bisphenol A is
used in the processing of polyvinyl
chloride plastic. Some polymers used in
dental sealants and composites may
contribute to bisphenol A exposures.
The primary source of exposure to
bisphenol A for most people is assumed
to occur through the diet. The highest
estimated daily intakes of bisphenol A
in the general population occur in
infants and children. CERHR selected
bisphenol A for evaluation because of
(1) widespread human exposure, (2)
public concern for possible health
effects, (3) high production volume, and
(4) evidence of reproductive and
developmental toxicity in laboratory
animal studies.
Background Information on the CERHR
The NTP established CERHR in 1998
(Federal Register: December 14, 1998:
Vol. 63, No. 239, page 68782). CERHR
is a publicly accessible resource for
information about adverse reproductive
and/or developmental health effects
associated with exposure to
environmental and/or occupational
exposures. CERHR follows a formal
process for the evaluation of selected
chemicals that includes opportunities
for public input.
CERHR invites the nomination of
agents for review or scientists for its
expert registry. Information about
CERHR and the nomination process can
be obtained from its homepage (https://
cerhr.niehs.nih.gov) or by contacting Dr.
Michael Shelby, CERHR Director (see
ADDRESSES). CERHR selects chemicals
for evaluation based upon several
factors including production volume,
potential for human exposure from use
and occurrence in the environment,
extent of public concern, and extent of
data from reproductive and
developmental toxicity studies. Expert
panels conduct scientific evaluations of
agents selected by CERHR in public
VerDate Aug<31>2005
22:59 Sep 02, 2008
Jkt 214001
forums. Following these evaluations,
CERHR prepares the NTP–CERHR
monograph on the agent evaluated. The
monograph is transmitted to appropriate
federal and state agencies and made
available to the public.
Dated: August 20, 2008.
Samuel H. Wilson,
Acting Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E8–20297 Filed 9–2–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘Study
of Factors Influencing Consumer
Choices Among Health Plans and
Clinicians.’’ In accordance with the
Paperwork Reduction Act of 1995,
Public Law 104–13 (44 U.S.C.
3506(c)(2)(A)), AHRQ invites the public
to comment on this proposed
information collection.
DATES: Comments on this notice must be
received by November 3, 2008.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@ahrq.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
‘‘Study of Factors Influencing
Consumer Choices Among Health Plans
and Clinicians’’
This study will use an experimental
design to determine factors that
influence consumer understanding and
use of performance information to select
among health plans and clinicians.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Performance reports on health plans and
individual providers have become
increasingly available in recent years,
but there is little evidence regarding
how consumers understand and use
different types of performance
information to make choices.
The study will include two parallel
experiments, one designed to assess
factors influencing choice of health
plans and one designed to assess factors
influencing choice of individual
doctors. Both experiments will present
a panel of online consumers with a
simulated Web-based performance
report. Study subjects will answer a
series of pre-test questions, and then be
directed to a Web site with a simulated
report (for either health plans or
doctors) where they will view various
types of performance information, go
through the process of selecting either a
health plan or a doctor, and then
complete the experiment by answering
a series of post-test questions about how
they made their selection.
The categories of performance
information to be included in the Web
reports will be derived from patient
experience survey results using
Consumer Assessment of Healthcare
Providers and Systems (CAHPS)
composite measures, clinical process
measures, personal anecdotes based on
patient or enrollee experiences, and the
frequency of different types of enrollee
complaints or grievances (in the plan
experiment only).
The results of this study will be used
to develop recommendations for helping
consumers to better understand and
more effectively use complex
information to select health plans and
providers, with the aim of making
performance information less
burdensome and more accessible,
useful, and transparent to the public.
The simulated Web-based reports will
be made available as examples for other
report developers to use. This study is
being conducted pursuant to AHRQ’s
statutory mandate to promote health
care quality improvement by conducting
and supporting research that develops
and presents scientific evidence
regarding all aspects of health care, 42
U.S.C. 299(b)(1), and to conduct
research on health care and on systems
for the delivery of such health care, 42
U.S.C. 299a.
Method of Collection
Participants in this study will be
recruited through the Knowledge
Networks national online panel of
consumers. For both the health plan and
clinician choice experiments, study
subjects will be randomly assigned to
one of several arms (described below)
E:\FR\FM\03SEN1.SGM
03SEN1
]]>Agencies
[Federal Register Volume 73, Number 171 (Wednesday, September 3, 2008)]
[NOT]
[Pages 51483-51484]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20297]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program (NTP) Center for the Evaluation of
Risks to Human Reproduction (CERHR) Announces the Availability of the
NTP-CERHR Monograph on Bisphenol A
AGENCY: National Institute of Environmental Health Sciences (NIEHS),
National Institutes of Health (NIH).
ACTION: Availability of the NTP-CERHR Monograph on Bisphenol A.
-----------------------------------------------------------------------
SUMMARY: In December 2005, the CERHR announced its intention to conduct
an evaluation of the potential for bisphenol A to cause adverse effects
on reproduction and development in humans (Federal Register: December
21, 2005: Vol. 70, No. 244, page 75827). The final results of this
evaluation are now available in the NTP-CERHR Monograph on Bisphenol A
that includes the (1) NTP Brief on Bisphenol A and (2) CERHR Expert
Panel Report on the Reproductive and Developmental Toxicity of
Bisphenol A. The NTP Brief provides the public, as well as government
health, regulatory, and research agencies, with the NTP's conclusions
regarding the potential for bisphenol A to adversely affect human
reproductive health or children's development. The NTP Brief is based
on information about bisphenol A provided in the expert panel report,
public comments, comments from peer reviewers of the draft NTP Brief,
and additional scientific information available since the expert panel
meeting.
DATES: The NTP-CERHR Monograph on Bisphenol A will be available on
September 3, 2008.
ADDRESSES: The NTP-CERHR Monograph on the Potential Human Reproductive
and Developmental Effects of Bisphenol A is now available
electronically on the CERHR Web site (https://cerhr.niehs.nih.gov see
``Now Available'') or on CD or in printed text from the CERHR by
contacting Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box
12233, MC EC-32, Research Triangle Park, NC 27709 (mail), 919-316-4511
(fax), or shelby@niehs.nih.gov (e-mail). Courier address: CERHR, 79
T.W. Alexander Drive, Building 4401, Room 103, Research Triangle Park,
NC 27709. Additional information related to the evaluation of bisphenol
A, including the peer review report for the NTP Brief and all public
comments received during the course of the evaluation, are available on
the CERHR Web site (see Bisphenol
[[Page 51484]]
A under ``CERHR Reports & Monographs'' or directly at https://
cerhr.niehs.nih.gov/chemicals/bisphenol/bisphenol-eval.html.)
SUPPLEMENTARY INFORMATION:
Background Information on Bisphenol A
Bisphenol A (CAS RN: 80-05-7) is a high production volume chemical
used primarily in the production of polycarbonate plastics and epoxy
resins. Polycarbonate plastics are used in some food and drink
containers; the resins are used as lacquers to coat metal products such
as food cans, bottle tops, and water supply pipes. To a lesser extent
bisphenol A is used in the production of polyester resins, polysulfone
resins, polyacrylate resins, and flame retardants. In addition,
bisphenol A is used in the processing of polyvinyl chloride plastic.
Some polymers used in dental sealants and composites may contribute to
bisphenol A exposures. The primary source of exposure to bisphenol A
for most people is assumed to occur through the diet. The highest
estimated daily intakes of bisphenol A in the general population occur
in infants and children. CERHR selected bisphenol A for evaluation
because of (1) widespread human exposure, (2) public concern for
possible health effects, (3) high production volume, and (4) evidence
of reproductive and developmental toxicity in laboratory animal
studies.
Background Information on the CERHR
The NTP established CERHR in 1998 (Federal Register: December 14,
1998: Vol. 63, No. 239, page 68782). CERHR is a publicly accessible
resource for information about adverse reproductive and/or
developmental health effects associated with exposure to environmental
and/or occupational exposures. CERHR follows a formal process for the
evaluation of selected chemicals that includes opportunities for public
input.
CERHR invites the nomination of agents for review or scientists for
its expert registry. Information about CERHR and the nomination process
can be obtained from its homepage (https://cerhr.niehs.nih.gov) or by
contacting Dr. Michael Shelby, CERHR Director (see ADDRESSES). CERHR
selects chemicals for evaluation based upon several factors including
production volume, potential for human exposure from use and occurrence
in the environment, extent of public concern, and extent of data from
reproductive and developmental toxicity studies. Expert panels conduct
scientific evaluations of agents selected by CERHR in public forums.
Following these evaluations, CERHR prepares the NTP-CERHR monograph on
the agent evaluated. The monograph is transmitted to appropriate
federal and state agencies and made available to the public.
Dated: August 20, 2008.
Samuel H. Wilson,
Acting Director, National Institute of Environmental Health Sciences
and National Toxicology Program.
[FR Doc. E8-20297 Filed 9-2-08; 8:45 am]
BILLING CODE 4140-01-P
